Federal regulation of the advertising and promotion of pharmaceuticals and medical devices reflects an aggressive attitude on the part of the regulators that demands, in turn, that industry be keenly aware of the legal and regulatory duties, as well as key recent trends in enforcement activities by the Federal Government.
This course will explore in detail what FDA requires of drug and device firms as well as recent current hot buttons in FDA enforcement activity for the advertising arena.
Please contact Kathleen Baldwin, Sales Support Manager at NJMEP with any questions or need of further assistance. firstname.lastname@example.org 973-998-9801 ext. 211